“…Drug diffusion through C. albicans biofilm is directly associated with its susceptibility to antifungal therapy, mainly due to polymeric substances of extracellular matrix [ 60 ]. Studies revealed that the concentration and release rate of compounds are important factors for their penetration on biofilms [ 61 , 62 , 63 ]. Al-Fattani and Douglas [ 61 ] analyzed the penetration of several antifungals (fluconazole, amphotericin B and voriconazole) into Candida biofilms, verifying that the drug reached the distal edges of biofilms only when it was used in concentrations substantially higher than the MIC values.…”
Section: Discussionmentioning
confidence: 99%
“…Al-Fattani and Douglas [ 61 ] analyzed the penetration of several antifungals (fluconazole, amphotericin B and voriconazole) into Candida biofilms, verifying that the drug reached the distal edges of biofilms only when it was used in concentrations substantially higher than the MIC values. Using a drug delivery system, Torabiardekani et al [ 63 ] and Karami et al [ 62 ] demonstrated that the encapsulation of essential oils in hydrogels provided their controlled and prolonged release for 270 min, which was associated with an enhanced activity against C. albicans biofilms. These results confirm that modern drug delivery systems based on hydrogels can assist by achieving better therapeutic effects with slower release process [ 13 ].…”
Candida albicans can cause various types of oral infections, mainly associated with denture stomatitis. Conventional therapy has been linked to high recurrence, toxicity, and fungal resistance, necessitating the search for new drugs and delivery systems. In this study, caffeic acid phenethyl ester (CAPE) and gellan gum (GG) were studied as an antifungal agent and carrier system, respectively. First, we observed that different GG formulations (0.6 to 1.0% wt/vol) were able to incorporate and release CAPE, reaching a controlled and prolonged release over 180 min at 1.0% of GG. CAPE-GG formulations exhibited antifungal activity at CAPE concentrations ranging from 128 to >512 µg/mL. Furthermore, CAPE-GG formulations significantly decreased the fungal viability of C. albicans biofilms at short times (12 h), mainly at 1.0% of GG (p < 0.001). C. albicans protease activity was also reduced after 12 h of treatment with CAPE-GG formulations (p < 0.001). Importantly, CAPE was not cytotoxic to human keratinocytes, and CAPE-GG formulations at 1.0% decreased the fungal burden (p = 0.0087) and suppressed inflammation in a rat model of denture stomatitis. Altogether, these results indicate that GG is a promising delivery system for CAPE, showing effective activity against C. albicans and potential to be used in the treatment of denture stomatitis.
“…Drug diffusion through C. albicans biofilm is directly associated with its susceptibility to antifungal therapy, mainly due to polymeric substances of extracellular matrix [ 60 ]. Studies revealed that the concentration and release rate of compounds are important factors for their penetration on biofilms [ 61 , 62 , 63 ]. Al-Fattani and Douglas [ 61 ] analyzed the penetration of several antifungals (fluconazole, amphotericin B and voriconazole) into Candida biofilms, verifying that the drug reached the distal edges of biofilms only when it was used in concentrations substantially higher than the MIC values.…”
Section: Discussionmentioning
confidence: 99%
“…Al-Fattani and Douglas [ 61 ] analyzed the penetration of several antifungals (fluconazole, amphotericin B and voriconazole) into Candida biofilms, verifying that the drug reached the distal edges of biofilms only when it was used in concentrations substantially higher than the MIC values. Using a drug delivery system, Torabiardekani et al [ 63 ] and Karami et al [ 62 ] demonstrated that the encapsulation of essential oils in hydrogels provided their controlled and prolonged release for 270 min, which was associated with an enhanced activity against C. albicans biofilms. These results confirm that modern drug delivery systems based on hydrogels can assist by achieving better therapeutic effects with slower release process [ 13 ].…”
Candida albicans can cause various types of oral infections, mainly associated with denture stomatitis. Conventional therapy has been linked to high recurrence, toxicity, and fungal resistance, necessitating the search for new drugs and delivery systems. In this study, caffeic acid phenethyl ester (CAPE) and gellan gum (GG) were studied as an antifungal agent and carrier system, respectively. First, we observed that different GG formulations (0.6 to 1.0% wt/vol) were able to incorporate and release CAPE, reaching a controlled and prolonged release over 180 min at 1.0% of GG. CAPE-GG formulations exhibited antifungal activity at CAPE concentrations ranging from 128 to >512 µg/mL. Furthermore, CAPE-GG formulations significantly decreased the fungal viability of C. albicans biofilms at short times (12 h), mainly at 1.0% of GG (p < 0.001). C. albicans protease activity was also reduced after 12 h of treatment with CAPE-GG formulations (p < 0.001). Importantly, CAPE was not cytotoxic to human keratinocytes, and CAPE-GG formulations at 1.0% decreased the fungal burden (p = 0.0087) and suppressed inflammation in a rat model of denture stomatitis. Altogether, these results indicate that GG is a promising delivery system for CAPE, showing effective activity against C. albicans and potential to be used in the treatment of denture stomatitis.
“…Some research papers have recently drawn attention to the use of CS as a gelling agent in emulgel compositions for the management of skin dermatitis, wound healing, and tissue regeneration [24][25][26]. To our best knowledge, there are a limited number of studies devoted to the application of CS and PO or pomegranate extract in food or cosmetic technology [27,28] and no research data focused on the use of CS and PO in the pharmaceutical technology of drug delivery systems.…”
Multifunctional delivery systems capable of modulating drug release and exerting adjunctive pharmacological activity have attracted particular attention. Chitosan (CS) and pomegranate seed oil (PO) appear to be attractive bioactive components framing the strategy of complex therapy and multifunctional drug carriers. This research is aimed at evaluating the potential of CS in combination with PO in studies on topical emulgels containing hydrocortisone as a model anti-inflammatory agent. Its particular goal was to distinguish alterations in anti-inflammatory action followed with drug dissolution or penetrative behavior between the designed formulations that differ in CS/PO weight ratio. All formulations favored hydrocortisone release with up to a two-fold increase in the drug dissolution rate within first 5 h as compared to conventional topical preparations. The clear effect of CS/PO on the emulgel biological performance was observed, and CS was found to be prerequisite for the modulation of hydrocortisone absorption and accumulation. In turn, a greater amount of PO played the predominant role in the inhibition of hyaluronidase activity and enhanced the anti-inflammatory effect of preparation E-3. Emulgels showed a negligible reduction in mouse fibroblasts’ L929 cell viability, confirming their non-irritancy with skin cells. Overall, the designed formulation with a CS/PO ratio of 6:4 appeared to be the most promising topical carrier for the effective treatment of inflammatory skin diseases among the tested subjects.
“…However, the overuse or even abuse of antibiotics has greatly exacerbated bacterial resistance toward almost all kinds of antibiotics, resulting in serious consequences for anti-infection treatment. − Thus, it is of extreme importance to develop new strategies for combating MDR bacteria. It is well known that bacterial infections commonly occur in biofilms in which bacterial cells are protected by extracellular polymeric substances (EPS). , Numerous human diseases are caused by biofilms. − For example, dental caries is a worldwide disease caused by the dynamic interactions of cariogenic and commensal microbes within dental plaque (biofilms) on tooth surfaces . It needs over 1000-fold common antibiotics to eradicate metabolically active bacteria in biofilms than planktonic bacteria. − Thus, from a therapeutic perspective, it is particularly significant to develop new antibacterial agents that can not only kill the MDR bacteria effectively but also disrupt the biofilms.…”
Glycopolymer-supported silver nanoparticles (AgNPs) have demonstrated a promising alternative to antibiotics for the treatment of multidrug-resistant bacteria-infected diseases. In this contribution, we report a class of biohybrid glycopolymersome-supported AgNPs, which are capable of effectively killing multidrug-resistant bacteria and disrupting related biofilms. First of all, glycopolymersomes with controllable structures were massively fabricated through reversible addition−fragmentation chain transfer (RAFT) polymerization-induced self-assembly (PISA) in an aqueous solution driven by complementary hydrogen bonding interaction between the pyridine and amide groups of N-(2methylpyridine)-acrylamide (MPA) monomers. Subsequently, Ag + captured by glycopolymersomes through the coordination between pyridine-N and Ag + was reduced into AgNPs stabilized by glycopolymersomes upon addition of the NaBH 4 reducing agent, leading to the formation of the glycopolymersome@AgNPs biohybrid. As a result, they showed a wide-spectrum and enhanced removal of multidrug-resistant bacteria and biofilms compared to naked AgNPs due to the easier adhesion onto the bacterial surface and diffusion into biofilms through the specific protein−carbohydrate recognition. Moreover, the in vivo results revealed that the obtained biohybrid glycopolymersomes not only demonstrated an effective treatment for inhibiting the cariogenic bacteria but also were able to repair the demineralization of caries via accumulating Ca 2+ through the recognition between carbohydrates and Ca 2+ . Furthermore, glycopolymersomes@AgNPs showed quite low in vitro hemolysis and cytotoxicity and almost negligible acute toxicity in vivo. Overall, this type of biohybrid glycopolymersome@AgNPs nanomaterial provides a new avenue for enhanced antibacterial and antibiofilm activities and the effective treatment of oral microbial-infected diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.